Estrogen receptor downregulators: new antihormonal therapy for advanced breast cancer

Clinical Therapeutics
J F R Robertson

Abstract

Fulvestrant is the first agent in the new class of estrogen receptor (ER) downregulators to be evaluated in clinical studies. The binding of ER downregulators to ERs inhibits the activation functions of the receptors (AF-1 and AF-2). ER downregulators also disrupt the dimerization and nuclear localization of ERs. In contrast to ER downregulators, when selective estrogen receptor modulators (SERMs) bind to ERs, only AF-2 is inhibited; AF-1 remains active. Therefore, with SERMs, AF-1 can still recruit coactivators, which results in a partially inactivated transcription and a reduced rate of tumor cell division. Consistent with its mechanism of action, animal models have shown that fulvestrant demonstrates a longer suppression of tumor growth than does tamoxifen, and it has antitumor activity in tamoxifen-resistant tumors. Two Phase III trials have been conducted comparing fulvestrant (250 mg IM monthly) with anastrozole (1 mg oral tablet daily) in postmenopausal patients with advanced breast cancer progressing after prior endocrine therapy. Objective response in fulvestrant-treated patients in the 2 studies ranged from 17.5% to 20.7% compared with 15.7% to 17.5% for anastrozole-treated patients, and the median duration of respons...Continue Reading

References

Mar 1, 1987·The Journal of Endocrinology·A E Wakeling, J Bowler
May 17, 1995·Journal of the National Cancer Institute·C K OsborneR I Nicholson
Jan 1, 1994·Cancer Chemotherapy and Pharmacology·C K OsborneA E Wakeling
Nov 11, 1993·International Journal of Cancer. Journal International Du Cancer·X F HuJ R Zalcberg
Jan 15, 1994·International Journal of Cancer. Journal International Du Cancer·P CoopmanH Rochefort
Jan 1, 1993·Breast Cancer Research and Treatment·A E Wakeling
Nov 26, 1998·The New England Journal of Medicine·C K Osborne

❮ Previous
Next ❯

Citations

Jul 16, 2002·Clinical Therapeutics·Frank J Cummings
Aug 17, 2010·Advanced Drug Delivery Reviews·Erin K Shanle, Wei Xu
Dec 18, 2007·Frontiers in Neuroendocrinology·Nandini Vasudevan, Donald W Pfaff
Jan 31, 2006·Expert Opinion on Therapeutic Targets·Vishwanie S Budhram-Mahadeo, David S Latchman
Oct 5, 2006·Endocrine Reviews·Nandini Vasudevan, Donald W Pfaff
Apr 25, 2015·Nature Reviews. Cancer·Cynthia X MaMatthew J Ellis
Dec 23, 2008·Clinical Privilege White Paper
Jun 17, 2003·Clinical Obstetrics and Gynecology·Michael W Draper, William W Chin
Nov 8, 2002·The Journal of Nutrition·Delia M BrownsonTom J Mabry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.